Omidenepag: A New Category of Topical Glaucoma Therapy
Dec 30, 2022•46 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Drs. Amanda Bicket and Lori Provencher join Dr. Andrew Pouw to discuss omidenepag isopropyl (Omlonti), the recently FDA-approved eye drop for treating elevated IOP in patients with primary open-angle glaucoma or ocular hypertension.
For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
For the best experience, listen in Metacast app for iOS or Android